Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8AYH

Structure of Complement C5 in Complex with small molecule inhibitor and CVF

Replaces:  6I2X
Summary for 8AYH
Entry DOI10.2210/pdb8ayh/pdb
EMDB information15713
DescriptorComplement C5 beta chain, Complement C5 alpha chain, Cobra venom factor, ... (5 entities in total)
Functional Keywordsinhibitor, protease, complex, cryo-em, toxin, immune system
Biological sourceHomo sapiens (human)
More
Total number of polymer chains3
Total formula weight371446.33
Authors
Srinivas, H. (deposition date: 2022-09-02, release date: 2022-12-21, Last modification date: 2024-10-09)
Primary citationJendza, K.,Kato, M.,Salcius, M.,Srinivas, H.,De Erkenez, A.,Nguyen, A.,McLaughlin, D.,Be, C.,Wiesmann, C.,Murphy, J.,Bolduc, P.,Mogi, M.,Duca, J.,Namil, A.,Capparelli, M.,Darsigny, V.,Meredith, E.,Tichkule, R.,Ferrara, L.,Heyder, J.,Liu, F.,Horton, P.A.,Romanowski, M.J.,Schirle, M.,Mainolfi, N.,Anderson, K.,Michaud, G.A.
A small-molecule inhibitor of C5 complement protein.
Nat.Chem.Biol., 15:666-668, 2019
Cited by
PubMed Abstract: The complement pathway is an important part of the immune system, and uncontrolled activation is implicated in many diseases. The human complement component 5 protein (C5) is a validated drug target within the complement pathway, as an anti-C5 antibody (Soliris) is an approved therapy for paroxysmal nocturnal hemoglobinuria. Here, we report the identification, optimization and mechanism of action for the first small-molecule inhibitor of C5 complement protein.
PubMed: 31209353
DOI: 10.1038/s41589-019-0303-9
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.35 Å)
Structure validation

237423

數據於2025-06-11公開中

PDB statisticsPDBj update infoContact PDBjnumon